Angiogenesis in myelodysplastic syndromes

Giancarlo Pruneri(University of Milan), Francesco Pezzella(Cancer Research UK), Francesco Bertolini(European Institute of Oncology), Agostino Cortelezzi(Istituti di Ricovero e Cura a Carattere Scientifico), Roberto Buffa, Giorgio Lambertenghi‐Deliliers(Ospedale Maggiore), Pier Francesco Ferrucci(MultiMedica), Davide Soligo, Nadia Carboni

British Journal of Cancer

November 26, 1999

10.1038/sj.bjc.6693515

Cited by 272

Related Papers

ecancermedicalscience

|ecancermedicalscience|2016|679

The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells

|Cell|1993|610

Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)

|Blood|2009|433

Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab

|Annals of Oncology|2016|398

Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial

|Journal of Clinical Oncology|2016|394